Gene · 25833
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unmasking biomarkers in small cell lung cancer: implication for precision oncology. | Front Oncol | 2026 | 42444834 | PubTator, text mining | PubMed |
| CD68+ tumor-associated macrophages exhibit prognostic value in surgically resected small cell lung cancer: a retrospective cohort study of 614 patients. | Cancer Immunol Immunother | 2026 | 42371090 | PubTator, text mining | PubMed |
| POU2F3-positive small cell neuroendocrine carcinoma of the urinary tract: a clinicopathological analysis of five cases. | Front Oncol | 2026 | 42370135 | PubTator, text mining | PubMed |
| Presence of Tuft Cells Expressing Hematopoietic Prostaglandin D Synthase in Acinar-to-Ductal Metaplasia in Human Obstructive Pancreatitis. | Curr Issues Mol Biol | 2026 | 42353590 | PubTator, text mining | PubMed |
| A decade of progress in small-cell lung cancer (2015-2025): a narrative review. | Eur J Clin Pharmacol | 2026 | 42324360 | PubTator, text mining | PubMed |
| Dual Mechanisms Underlie the Repression of Repressor Element 1-Silencing Transcription Factor Expression in Lung Neuroendocrine Carcinoma Cells. | Am J Pathol | 2026 | 42314925 | PubTator, text mining | PubMed |
| Comparison of protein-based and genetic prognostic markers in a large cohort of primary pulmonary and extrapulmonary small cell neuroendocrine carcinoma. | Lung Cancer | 2026 | 42217423 | PubTator, text mining | PubMed |
| Pan-cancer analysis and mechanistic insights of tuft cell-like tumors. | Genes Dis | 2026 | 42211052 | PubTator, text mining | PubMed |
| Case Report: Neuroendocrine-marker-negative high-grade neuroendocrine carcinoma mimicking squamous cell carcinoma: an underrecognized diagnostic pitfall. | Front Immunol | 2026 | 42183205 | PubTator, text mining | PubMed |
| Epigenomic profiling of neuroendocrine lung cancers identifies a classical-neuroendocrine ASCL1/NKX2-1 subtype and a SOX11-associated differentiation axis linked to reduced immunogenicity. | Lung Cancer | 2026 | 42160949 | PubTator, text mining | PubMed |
| Extensive-stage small cell esophageal carcinoma: a retrospective analysis of treatment modalities. | BMC Cancer | 2026 | 42151858 | PubTator, text mining | PubMed |
| Presence of tuft cells expressing haematopoietic prostaglandin D synthase in intraductal papillary mucinous neoplasms of the pancreas. | Mol Clin Oncol | 2026 | 42147139 | PubTator, text mining | PubMed |
| POU2F3 expression in lung squamous cell carcinoma: transcriptomic and immunohistochemical profiling with prognosis. | Jpn J Clin Oncol | 2026 | 42116766 | PubTator, text mining | PubMed |
| Association of tumor CD73 expression with clinical outcomes in small cell lung cancer treated with first-line chemo-immunotherapy. | Lung Cancer | 2026 | 42061276 | PubTator, text mining | PubMed |
| Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance. | Respir Investig | 2026 | 42054725 | PubTator, text mining | PubMed |
| Aging and degradation behaviour of poly(lactic acid) composites in alcoholic and acidic food simulants. | RSC Adv | 2026 | 42028192 | PubTator, text mining | PubMed |
| Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer. | bioRxiv | 2026 | 41993528 | PubTator, text mining | PubMed |
| Highlights of Tuft Cells in Mouse and Human Salivary Glands. | Cells | 2026 | 41972672 | PubTator, text mining | PubMed |
| Inducible POU Class 2 Homeobox 3 Expression in Human Intestinal Organoids as a Model of Human Tuft Cells. | Cell Mol Gastroenterol Hepatol | 2026 | 41956399 | PubTator, text mining | PubMed |
| POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors. | Lab Invest | 2026 | 41956344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25833/papers?page=2